ClinicalTrials.Veeva

Menu

Developmental Effects of Infant Formula Supplemented With LCPUFA

Mead Johnson Nutrition logo

Mead Johnson Nutrition

Status

Completed

Conditions

Cognitive Development
Growth

Treatments

Other: Control
Other: DHA and ARA

Study type

Interventional

Funder types

Industry

Identifiers

NCT00753818
3370-2(-4)

Details and patient eligibility

About

The purpose of this study is to compare the effects on visual development, growth, cognitive development, tolerance, and blood chemistry parameters in term infants fed one of four study formulas containing various levels of DHA and ARA.

Sex

All

Ages

1 to 5 days old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • healthy, term, formula fed infants from 1-5 days of age

Exclusion criteria

  • history of disease that effects normal growth and development
  • breast fed, or formula intolerance

Trial design

0 participants in 4 patient groups

1
Experimental group
Treatment:
Other: DHA and ARA
2
Experimental group
Treatment:
Other: DHA and ARA
3
Experimental group
Treatment:
Other: DHA and ARA
4
Other group
Description:
Control
Treatment:
Other: Control

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems